Navigation Links
Keryx Biopharmaceuticals Announces Upcoming Poster Presentation of Zerenex™ (ferric citrate) at the 49th ERA-EDTA Congress
Date:5/21/2012

s release speak only as of the date of this press release. We do not undertake to update any of these forward-looking statements to reflect events or circumstances that occur after the date hereof. This press release and prior releases are available at http://www.keryx.com. The information found on our website, and the M Events website, is not incorporated by reference into this press release and are included for reference purposes only.

KERYX CONTACT:
Lauren Fischer
Director - Investor Relations
Keryx Biopharmaceuticals, Inc.
Tel: 212.531.5965
E-mail: lfischer@keryx.com

 

 


'/>"/>
SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference
2. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
3. Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology
4. Keryx Biopharmaceuticals Completes SUN-MICRO Phase 3 Pivotal Trial
5. Keryx Biopharmaceuticals Announces that the SUN-MICRO Phase 3 Clinical Trial Failed to Meet its Primary Efficacy Endpoint
6. Keryx Biopharmaceuticals Announces Termination of SUN-MACRO Phase 4 Trial
7. Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois
8. Keryx Biopharmaceuticals, Inc. Announces Phase 2 Results on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Waldenstroms Macroglobulinemia at the 44th Annual Meeting of the American Society of Clinical Oncology
9. Keryx Biopharmaceuticals, Inc. Reports Phase 1/2 Data on KRX-0401 (Perifosine) at 50th Annual Meeting of American Society of Hematology
10. Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data on KRX-0401 (Perifosine) in Combination with Bortezomib (+/- Dexamethasone) at the 12th International Multiple Myeloma Meeting
11. Keryx Biopharmaceuticals Reports Single Agent Phase 2 Data of KRX-0401 (Perifosine) Further Demonstrating KRX-0401s Activity in the Treatment of Advanced Metastatic Renal Cell Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... July 29, 2014 Edwards Lifesciences Corporation (NYSE: ... heart valves and hemodynamic monitoring, today reported net income for ... $5.09 per diluted share, and non-GAAP net income of $94.0 ... same period a year earlier was $93.3 million, or $0.81 ... or $0.84 per diluted share.  Net sales ...
(Date:7/29/2014)... 29, 2014 New technology in the form ... physicians to see and assess brain tissue more clearly ... study authors who released their findings today at the ... Meeting in Colorado Springs, CO. ... of neurointervention, a specialty that facilitates stroke treatment by ...
(Date:7/29/2014)... -- McGraw-Hill Education Professional, a leading global provider of ... communities, has announced the launch of the AccessMedicine ... world-renowned medical education platform. A key ... for download onto all iOS and Android devices, is ... to valuable AccessMedicine diagnostic resources in an ...
Breaking Medicine Technology:Edwards Lifesciences Reports Strong Second Quarter Results 2Edwards Lifesciences Reports Strong Second Quarter Results 3Edwards Lifesciences Reports Strong Second Quarter Results 4Edwards Lifesciences Reports Strong Second Quarter Results 5Edwards Lifesciences Reports Strong Second Quarter Results 6Edwards Lifesciences Reports Strong Second Quarter Results 7Edwards Lifesciences Reports Strong Second Quarter Results 8Edwards Lifesciences Reports Strong Second Quarter Results 9Edwards Lifesciences Reports Strong Second Quarter Results 10Edwards Lifesciences Reports Strong Second Quarter Results 11Edwards Lifesciences Reports Strong Second Quarter Results 12Edwards Lifesciences Reports Strong Second Quarter Results 13Edwards Lifesciences Reports Strong Second Quarter Results 14Edwards Lifesciences Reports Strong Second Quarter Results 15Edwards Lifesciences Reports Strong Second Quarter Results 16Edwards Lifesciences Reports Strong Second Quarter Results 17Edwards Lifesciences Reports Strong Second Quarter Results 18Edwards Lifesciences Reports Strong Second Quarter Results 19Edwards Lifesciences Reports Strong Second Quarter Results 20Edwards Lifesciences Reports Strong Second Quarter Results 21Edwards Lifesciences Reports Strong Second Quarter Results 22Edwards Lifesciences Reports Strong Second Quarter Results 23Edwards Lifesciences Reports Strong Second Quarter Results 24Edwards Lifesciences Reports Strong Second Quarter Results 25New Technology May Improve Visualization Of The Brain During Stroke Treatment 2New Technology May Improve Visualization Of The Brain During Stroke Treatment 3McGraw-Hill Education Professional's AccessMedicine App Delivers Instant Access to Essential Diagnostic Tools 2McGraw-Hill Education Professional's AccessMedicine App Delivers Instant Access to Essential Diagnostic Tools 3
... Nov. 11, 2010 /PRNewswire-Asia-FirstCall/ -- American Oriental Bioengineering, ... or "AOBO"), a pharmaceutical company dedicated to improving ... a broad range of prescription and over-the-counter ("OTC") ... Wujia Rongxue Oral Liquid, ("AWRO Liquid"), an OTC ...
... Nov. 11, 2010 Misonix, Inc. (Nasdaq: ... ultrasonic medical device technology, which worldwide is used for ... quarter ended September 30, 2010 financial results on Monday, ... Executive Officer and Richard Zaremba, Senior VP and Chief ...
Cached Medicine Technology:American Oriental Bioengineering Introduces Wujia Rongxue Oral Liquid 2Misonix Schedules First Quarter 2011 Financial Results Conference Call; November 15, 2010 at 4:30 P.M. Eastern 2
(Date:7/29/2014)... St. Petersburg, FL (PRWEB) July 30, 2014 Phytceramides ... explains how and why in her new book. , Today is ... Phytoceramides: Anti Aging At Its Best . The book is ... larger skin care book, but felt that Phytoceramides were ... sense to bring out this focused book now," says Kathy Heshelow, ...
(Date:7/29/2014)... Daily Gossip indicates that the new method ... symptoms that hemorrhoids commonly causes. The new method was ... expert. , The author of H Miracle reveals ... symptoms such as itching, burning, pain and swelling, as ... H Miracle by visiting the official website at: ...
(Date:7/29/2014)... 29, 2014 Daily Gossip reveals in its ... program claims that he cured his condition with the use ... share part of his experience. , He claimed that ... naturally in just 4 days. Since his method turned out ... from all around the world. , The Nasal Polyps ...
(Date:7/29/2014)... 29, 2014 DailyGossip.org reveals in its ... is a new method of naturally overcoming sciatica, in ... the new method ensure sufferers that the cure is ... , The new method is described as very ... sciatica with an 8 minutes per day treatment plan. ...
(Date:7/29/2014)... DailyGossip.org reveals in its latest review that ... can perfectly understand patients and what they have to go ... is the author of the new program. Ellie claims that ... suffering, Ellie started her very own research. Four years passed ... author of the Get Rid of Cold Sores program claims ...
Breaking Medicine News(10 mins):Health News:Last Day New Book Is Available at No Cost: Phytoceramides, Anti Aging At Its Best by Sublime Beauty Founder® Kathy Heshelow 2Health News:Last Day New Book Is Available at No Cost: Phytoceramides, Anti Aging At Its Best by Sublime Beauty Founder® Kathy Heshelow 3Health News:H Miracle Review Exposes Natural Method to Cure Hemorrhoids 2Health News:Nasal Polyps Treatment Miracle Review Reveals How to Cure Nasal Polyps Without Surgery 2Health News:Stop Sciatica in 8 Minutes Review Reveals the Way to Cure Sciatica Easily 2Health News:Get Rid of Cold Sores Fast Review Exposes the Way to Stop Outbreaks 2
... apnea, a dangerous medical condition that becomes more prevalent as ... deadly if left// untreated, says an expert. ,The ... irritation, with people being unaware that they are causing more ... the online edition of health portal News Medical. ...
... 'An ounce of prevention is worth a pound of cure.' , ... disease that could wipe the smile// off many faces and cause ... 43% of all cancers are preventable. Sunday, 4 February 2007, is ... will focus on strategies for a cancer free world – a ...
... College of Medicine finds that naltrexone may be beneficial to ... is often used to bring// relief to victims of alcohol ... inflammatory disorder of the intestine that affects an estimated 500,000 ... an early edition of the American Journal of Gastroenterology. ...
... hair dye are increasing as more and younger people dye ... dermatitis on the face and, in severe cases, facial swelling ... dyes currently contain para-phenylenediamine (PPD) and other related agents. During ... serious problem that it was banned from hair dyes in ...
... A promising step forward in the field of AIDS was ... to this 2-5AN6B, a nucleic acid, could actually stop the// ... ,This work was led by Robert J.Suhadolnik, Professor of ... 2-5AN6B in combination with drugs currently used for AIDS treatment ...
... menstrual cycles affect the responsiveness of their brains’ reward ... Mental Health (NIMH), a component of the National Institutes ... women were winning rewards, their circuitry was more active ... and dominated by estrogen, compared to a phase when ...
Cached Medicine News:Health News:'Cancer Prevention' - In Your Hands 2Health News:'Cancer Prevention' - In Your Hands 3Health News:NIMH Studies Woman’s Hormonal Cycl 2
Open blade design with aspiration capabilities for removing fluids from the operative site. 19 gauge wire....
Speculum can be used for any type of eye surgery. Arms of speculum lie flat due to joint between blade and arms. Features quick locking mechanism....
Pediatric model. Spring-controlled spread of blades with locking mechanism. Dull finish. Blades: 11 mm....
Fenestrated blades with screw-controlled spread. Dull finish. Blades: 16 mm....
Medicine Products: